All articles by Srivani Venna

  1. Goldfinch acquires global rights to Takeda’s monoclonal antibody

    US-based clinical-stage biotechnology company Goldfinch Bio has entered an agreement with Japanese firm Takeda Pharmaceutical for global rights to a…
    Read More…

    4 Oct
  2. UK’s NICE rejects Roche’s Tecentriq for triple negative breast cancer

    The UK’s National Institute for Health and Care Excellence (NICE) has rejected the first targeted immunotherapy treatment for people with…
    Read More…

    3 Oct
  3. Sobi to purchase Dova Pharmaceuticals in $915m deal

    Swedish Orphan Biovitrum AB (Sobi) has agreed to acquire US-based Dova Pharmaceuticals in a transaction valued up to $915m. Dova…
    Read More…

    1 Oct
  4. Kinoxis secures US grant for opioid withdrawal treatment

    The US National Institutes of Health (NIH) has awarded a grant of up to $4.6m to University of Sydney spinout…
    Read More…

    30 Sep
  5. Roche’s Rituxan secures approval for first paediatric indication

    Roche has secured approval from the US Food and Drug Administration (FDA) for Rituxan (rituximab) for children with two rare…
    Read More…

    30 Sep
  6. FDA approves Darzalex combination for multiple myeloma treatment

    The US Food and Drug Administration (FDA) has approved the combined use of Darzalex (daratumumab) with bortezomib, thalidomide and dexamethasone…
    Read More…

    30 Sep
  7. NHS agrees to fund drug for children with incurable Batten disease

    The NHS in the UK has agreed to fund a drug for children with a rare degenerative disease, which leads…
    Read More…

    12 Sep
  8. Mallinckrodt to divest Canadian drug manufacturing unit for $250m

    Biopharmaceutical firm Mallinckrodt has agreed to sell its contract development and manufacturing subsidiary BioVectra to an affiliate of private equity…
    Read More…

    11 Sep
  9. Zogenix agrees to buy Modis Therapeutics for $400m

    Pharmaceutical company Zogenix has signed a definitive agreement to buy Modis Therapeutics in a deal worth approximately $400m, including an…
    Read More…

    28 Aug
  10. WHO says investment in new R&D tools can eradicate malaria

    The World Health Organization (WHO) has claimed that malaria can be eradicated with accelerated research and development (R&D), using new…
    Read More…

    23 Aug
Close
Close
Close

Go Top